Friday, November 2, 2018

Should Juul comment when contacted by a Bloomberg's journalist?

In this article published by Boomberg on November 1, the journalist reports that Juul's founders 'declined to comment". Is this the right strategy? Someone thought it could be they want to keep a low profile while the FDA investigation is underway. But they did take part not long ago in a TV segment aired October 3 on NBC News. True on October 29, the editorial board of Bloomberg published an opinion titled The FDA wakes up to the danger of e-cigarettes that was extremely negative, very much in tune with Mike Bloomberg's personal position. What about the adults who sue Juul products? Shouldn't they have a say? I don't recall that they were asked for comments.

No comments:

Post a Comment